Fulton also noted that Thayumanavan’s team had found another interesting thing: that a tripeptide found in cells called glutathione can trigger the reduction of the central linker. ’Given that some cancer cells are known to have high concentrations of glutathione, this work holds great promise and could lead to the development of a new class of ’smart’ drug delivery systems,’ he says.